細胞活力檢測市場規模、佔有率及成長分析（按產品、應用、最終用戶和地區分類）－產業預測（2026-2033）

預計到 2024 年，細胞活力檢測市場規模將達到 16.7 億美元，到 2025 年將達到 18.4 億美元，到 2033 年將達到 39.2 億美元，在預測期（2026-2033 年）內，複合年成長率為 9.94%。

細胞活力顯示是否存在活細胞，是細胞健康的關鍵指標，尤其是在受到毒性等化學和物理因素影響時。細胞活力檢測 (CVA) 對於評估細胞對病原體和藥物的反應至關重要，並在製藥和醫療保健行業中具有廣泛的潛在應用。目前，受藥物研發領域日益成長的關注，細胞活力檢測市場正經歷強勁成長。這些檢測在藥物研發的早期階段發揮關鍵作用，能夠評估化合物的功效、毒性和安全性。對創新治療方法的持續需求，以及不斷發展的製藥生物技術產業，正顯著推動對細胞活力檢測的需求，並凸顯其在現代生物醫學研究中的重要性。

細胞活力檢測市場促進因素

細胞活力檢測市場正在成長，主要得益於製藥公司持續加大研發投入，致力於開發針對各種疾病的新藥治療方法。製藥和生物技術產業高度依賴細胞活力檢測來促進藥物發現、評估毒性並評估新治療方法的療效。這些領域的持續創新推動了對能夠提供準確可靠數據的先進檢測方法的需求。這種對先進檢測方法的依賴不僅促進了藥物發現過程，也凸顯了細胞活力檢測在現代醫學研究和治療方法進步中的關鍵作用。

細胞活力檢測市場限制因素

細胞活力檢測市場面臨許多挑戰，其中最主要的原因是所需設備的高成本，這對新興醫療機構和預算有限的公司而言構成了重大障礙。此外，缺乏能夠操作這些先進儀器的合格專業人員和技術人員也加劇了這個問題。有限的資金使得中小企業難以聘請熟練人員，從而阻礙了它們有效利用這些檢測方法，並抑制了整體市場成長。因此，這些限制阻礙了細胞活力檢測領域的潛在進步和創新。

細胞活力檢測市場趨勢

細胞活力檢測市場正經歷強勁成長，這主要得益於技術的不斷進步和創新。製造商正在加速整合人工智慧 (AI) 和機器學習等先進技術，以提升數據分析和解讀能力。這種協同效應不僅提高了檢測的準確性和效率，還拓寬了其在各種研究和臨床環境中的應用範圍。此外，數據分析能力的提升也推動了更複雜、更易用的檢測系統的開發，從而促進了整個市場的發展。這一趨勢標誌著細胞研究和開發正朝著更智慧化和自動化的解決方案轉變。

目錄

介紹

• 調查目標
• 調查範圍
• 定義

調查方法

• 資訊收集
• 一手和二手資料方法
• 市場規模預測
• 市場假設與限制

執行摘要

• 全球市場展望
• 供需趨勢分析
• 細分市場機會分析

市場動態與展望

• 市場規模
• 市場動態
  • 促進因素和機遇
  • 限制與挑戰
• 波特的分析和影響

關鍵市場考察

• 關鍵成功因素
• 競爭程度
• 關鍵投資機會
• 市場生態系統
• 技術進步
• 監管環境
• 專利分析
• 價值鏈分析
• 用例分析
• 客戶和購買標準分析
• PESTEL 分析
• 總體經濟指標
• 市場吸引力指數

全球細胞活力檢測市場規模（按產品和複合年成長率分類）（2026-2033 年）

• 消耗品
• 裝置

全球細胞活力檢測市場規模（按應用及複合年成長率分類）（2026-2033 年）

• 基礎研究
• 幹細胞研究
• 藥物發現與開發
• 臨床和診斷用途
• 其他

全球細胞活力檢測市場規模（依最終用戶分類）及複合年成長率（2026-2033 年）

• 學術研究機構
• 製藥和生物技術公司
• 醫院和診斷實驗室
• 其他

全球細胞活力檢測市場規模及複合年成長率（2026-2033）

• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 英國
  • 德國
  • 西班牙
  • 法國
  • 義大利
  • 其他歐洲
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 亞太其他地區
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲
• 中東和非洲
  • GCC
  • 南非
  • 其他中東和非洲地區

競爭資訊

• 前五大公司對比
• 主要企業的市場定位（2025 年）
• 主要市場參與者所採取的策略
• 近期市場趨勢
• 公司市佔率分析（2025 年）
• 主要企業公司簡介
  • 公司詳情
  • 產品系列分析
  • 依業務板塊進行公司股票分析
  • 2021-2023年營收年比比較

主要企業簡介

• F. Hoffmann-La Roche AG
• Danaher Corporation
• Lonza Group AG
• Promega Corporation
• Charles River Laboratories International, Inc.
• Menarini Silicon Biosystems, Inc.
• Becton, Dickinson and Company
• Bio-Rad Laboratories, Inc.
• Macrogen Inc
• DiscoverX Corporation
• Corning Inc.
• Merck KGaA
• Thermo Fisher Scientific Inc.
• Perkinelmer, Inc.
• Biognosys
• Cell Signaling Technology, Inc.
• Lebermuth, Inc.
• Eurofins DiscoverX Products
• GE Healthcare
• Beckman Coulter,Inc.

結論與建議

Cell Viability Assays Market size was valued at USD 1.67 Billion in 2024 and is poised to grow from USD 1.84 Billion in 2025 to USD 3.92 Billion by 2033, growing at a CAGR of 9.94% during the forecast period (2026-2033).

Cell viability, indicating the presence of living cells, serves as a crucial marker of cellular health, particularly influenced by chemical or physical events such as toxicity. Cell viability assays (CVAs) are essential for evaluating the cellular responses to pathogens or pharmaceuticals, leading to extensive applications within the pharmaceutical and medical industries. The market for cell viability assays is currently experiencing robust growth, driven by the heightened focus on drug development. These assays are instrumental in early-stage drug discovery, enabling the assessment of compound efficacy, toxicity, and safety profiles. The continuous need for innovative therapies, paired with the expanding pharmaceutical and biotechnology sectors, is significantly propelling the demand for cell viability assays, highlighting their importance in modern biomedical research.

Top-down and bottom-up approaches were used to estimate and validate the size of the Cell Viability Assays market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Cell Viability Assays Market Segments Analysis

Global Cell Viability Assays Market is segmented by Product, application, end user and region. Based on Product, the market is segmented into Consumables, Instruments. Based on application, the market is segmented into Basic Research, Stem Cell Research, Drug Discovery & Development, Clinical & Diagnostic Applications, Other Applications. Based on end user, the market is segmented into Academic and Research Institutes, Pharmaceutical and Biotechnology Companies, Hospital and Diagnostic Laboratories, Other End Users. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & and Africa.

Driver of the Cell Viability Assays Market

The Cell Viability Assays market is experiencing growth driven by ongoing investments in research and development by manufacturers aiming to create new pharmaceutical treatments for diverse health conditions. The pharmaceutical and biotechnology industries heavily rely on cell viability assays to facilitate drug discovery, assess toxicity, and evaluate the effectiveness of new therapies. As innovation continues within these fields, there is an increasing demand for sophisticated assays that can provide accurate and reliable data. This reliance on advanced testing methods not only enhances the drug development process but also underscores the critical role of cell viability assays in modern medical research and therapeutic advancements.

Restraints in the Cell Viability Assays Market

The cell viability assays market faces significant challenges due to the high costs associated with the necessary instruments, which poses a considerable barrier for emerging medical providers and companies operating with restricted budgets. Additionally, the shortage of qualified professionals and technical experts to operate these advanced instruments further exacerbates the issue. Limited financial resources make it difficult for smaller enterprises to afford hiring skilled personnel, thereby hindering their ability to effectively utilize these assays and stifling overall market growth. As a result, these constraints are impeding the potential advancements and innovations within the cell viability sector.

Market Trends of the Cell Viability Assays Market

The Cell Viability Assays market is experiencing robust growth driven by continuous technological advancements and innovations. Manufacturers are increasingly integrating these assays with cutting-edge technologies such as artificial intelligence (AI) and machine learning, enhancing data analysis and interpretation capabilities. This synergy not only improves the accuracy and efficiency of assays but also expands their applications across various research and clinical settings. Additionally, the ability to leverage data analytics is fostering the development of more sophisticated and user-friendly assay systems, thereby propelling the overall market forward. The trend signifies a shift towards more intelligent, automated solutions in cell-based research and drug development.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Driver & Opportunities
  • Restraints & Challenges
• Porters Analysis & Impact
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Technological Advancement
• Regulatory Landscape
• Patent Analysis
• Value Chain Analysis
• Case Study Analysis
• Customer & Buying Criteria Analysis
• PESTEL Analysis
• Macro-Economic Indicators
• Market Attractiveness Index

Global Cell Viability Assays Market Size byProduct & CAGR (2026-2033)

• Market Overview
• Consumables
• Instruments

Global Cell Viability Assays Market Size byApplication & CAGR (2026-2033)

• Market Overview
• Basic Research
• Stem Cell Research
• Drug Discovery & Development
• Clinical & Diagnostic Applications
• Other Applications

Global Cell Viability Assays Market Size by End User & CAGR (2026-2033)

• Market Overview
• Academic and Research Institutes
• Pharmaceutical and Biotechnology Companies
• Hospital and Diagnostic Laboratories
• Other End Users

Global Cell Viability Assays Market Size & CAGR (2026-2033)

• North America, (Product, Application, End User)
  • US
  • Canada
• Europe, (Product, Application, End User)
  • UK
  • Germany
  • Spain
  • France
  • Italy
  • Rest of Europe
• Asia-Pacific, (Product, Application, End User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia Pacific
• Latin America, (Product, Application, End User)
  • Brazil
  • Rest of Latin America
• Middle East & Africa, (Product, Application, End User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2021-2023)

Key Company Profiles

• F. Hoffmann-La Roche AG
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Danaher Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Lonza Group AG
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Promega Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Charles River Laboratories International, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Menarini Silicon Biosystems, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Becton, Dickinson and Company
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bio-Rad Laboratories, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Macrogen Inc
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• DiscoverX Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Corning Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Merck KGaA
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Thermo Fisher Scientific Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Perkinelmer, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Biognosys
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cell Signaling Technology, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Lebermuth, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Eurofins DiscoverX Products
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• GE Healthcare
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Beckman Coulter,Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendation